Arkay Drug Co. v. Commissioner

3 T.C.M. 1194, 1944 Tax Ct. Memo LEXIS 51
CourtUnited States Tax Court
DecidedNovember 7, 1944
DocketDockets Nos. 1581 and 2055.
StatusUnpublished
Cited by2 cases

This text of 3 T.C.M. 1194 (Arkay Drug Co. v. Commissioner) is published on Counsel Stack Legal Research, covering United States Tax Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Arkay Drug Co. v. Commissioner, 3 T.C.M. 1194, 1944 Tax Ct. Memo LEXIS 51 (tax 1944).

Opinion

Arkay Drug Co. and Merit Drug Co. v. Commissioner.
Arkay Drug Co. v. Commissioner
Dockets Nos. 1581 and 2055.
United States Tax Court
1944 Tax Ct. Memo LEXIS 51; 3 T.C.M. (CCH) 1194; T.C.M. (RIA) 44364;
November 7, 1944
*51 Charles Hockhauser, Esq., 152 W. 42nd St., New York, N. Y., for the petitioners. J. Richard Riggles, Jr., Esq., for the respondent.

KERN

Memorandum Findings of Fact and Opinion

The Commissioner determined the following deficiencies in the income and excess-profits taxes of the petitioners for the fiscal years indicated:

Arkay Drug Co.
Excess-Profits
Fiscal yr. endedIncome TaxTaxDelinquency Pen.
January 31, 1940$1,064.06$729.21
January 31, 194187.02
Merit Drug Co.
October 31, 1939$1,627.74$1,271.14$11.93
October 31, 194079.53

The petitioners challenge the correctness of the respondent's determination in four particulars: That there was includible in their respective taxable incomes interest on promissory notes accrued during each tax year; that the notes were worth full face value in the year received; that compensation paid an officer of the corporation after sale of the corporate assets was not an allowable deduction; and that they are not entitled to report their gain from the sale of their assets on the installment basis.

The proceedings were consolidated for hearing.

Findings of Fact

The petitioners are corporations organized under*52 the laws of New York. They filed their several corporation income and excess-profits tax returns involved here with the collectors of internal revenue for the third and fourteenth districts of New York, on an accrual basis. Their books of account were also kept on an accrual basis.

Both petitioners were organized by Louis P. Kotok, who owned all their capital stock and who managed the businesses and directed their policies. Each corporation was organized for the purpose of conducting and, prior to April 24, 1939, did conduct a drug store in New York City. Petitioner, Arkay Drug Co., Inc., was incorporated in 1934; and petitioner, Merit Drug Co., Inc., was incorporated in 1935.

Because of Kotok's failing health it was decided to sell the two drug stores owned by petitioners, and on April 24, 1939, Kotok executed a bill of sale reciting, in essence, that the Ar-Kay Drug Co., Inc.,

"* * * for and in consideration of the sum of Twenty Five Thousand * * * Dollars * * * has bargained and sold * * * the drug store and drug business as a going concern together with all and singular the fixtures, chattels, goods, wares and merchandise now contained in or connected with the drug store located*53 at 130 Dyckman Street, in the Borough of Manhattan, City of New York, as more particularly enumerated in the schedule hereto annexed which is made a part hereof, together with the goodwill thereof, and all trade and business and trade name in and to and connected with the said drug store, including the name Ar-Kay Drug Co., except however Ko-dine."

There follows the usual warranty of title in the seller, and a covenant not to engage in a competing business within a specified area, and a statement of the agreement with reference to unpaid bills. Then appears this provision:

"The above consideration was paid as follows:

"The sum of $10,000 in cash for the goods, wares, stock and merchandise contained in the said store; the sum of $2,000 for the chattels, machinery and fixtures and the balance of $13,000 for the leasehold interest, as evidenced by the sub-lease on the aforementioned premises, and the good will of the business; the latter two items constituting the purchase money mortgage of $15,000."

Physical inventory and adjustments made in the closing of the sale increased the amount of consideration paid by $250.

A bill of sale identical in form and language, except for the *54 different name, address and amount of consideration, was executed on the same date for the drug store owned by Merit Drug Co., Inc.

At the time of the sale, Ar-Kay Drug Co., Inc. received $10,000 in cash, and 69 promissory notes, of which 67 were in the face amount of $210, one was for $180, and one note was for $1,000. The note for $1,000 matured and was paid, including interest, on October 24, 1939. The others matured at the rate of one each month beginning May 24, 1939, and all provided for interest at the rate of six percent per annum. These notes were secured by a chattel mortgage upon the fixtures. Nine of the notes for $210 matured and were paid in the fiscal year ended January 31, 1940.

The consideration recited by the bill of sale for the store owned by petitioner Merit Drug Co., Inc., was $30,000. Physical inventory, and adjustments made in the closing of the transaction resulted in an increase in the consideration paid to the extent of $250. The sum of $15,000 was paid in cash, and sixty-nine promissory notes of a total face value of $15,250, 67 of which were in the face amount of $210 each, and one of which was for $180, maturing monthly beginning May 24, 1939, and one*55 was in the face amount of $1,000 which matured and was paid October 24, 1939. The notes provided for 6 percent interest payable as each note became due.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Farha v. Commissioner
58 T.C. 526 (U.S. Tax Court, 1972)

Cite This Page — Counsel Stack

Bluebook (online)
3 T.C.M. 1194, 1944 Tax Ct. Memo LEXIS 51, Counsel Stack Legal Research, https://law.counselstack.com/opinion/arkay-drug-co-v-commissioner-tax-1944.